(Compl)Ex-Th17–T_reg cell inter-relationship

References

• Medzhitov R. Origin and physiological roles of inflammation. Nature 2008; 454:428-35; PMID:18650913; http://dx.doi.org/10.1038/nature07201
   PubMed Web of Science ®Google Scholar
• Rock KL, Latz E, Ontiveros F, Kono H. The sterile inflammatory response. Annu Rev Immunol 2010; 28:321-42; PMID:20307211; http://dx.doi.org/10.1146/annurev-immunol-030409-101311
   PubMed Web of Science ®Google Scholar
• Obermajer N, Wong JL, Edwards RP, Chen K, Scott M, Khader S, Kolls JK, Odunsi K, Billiar TR, Kalinski P. Induction and stability of human Th17 cells require endogenous NOS2 and cGMP-dependent NO signaling. J Exp Med 2013; 210(7):1433-445; PMID:23797095; http://dx.doi.org/10.1084/jem.20121277
   PubMed Web of Science ®Google Scholar
• Obermajer N, Popp FC, Soeder Y, Haarer J, Geissler EK, Schlitt HJ, Dahlke MH. Conversion of Th17 into IL-17Aneg regulatory T cells: a novel mechanism in prolonged allograft survival promoted by mesenchymal stem cell-supported minimized immunosuppressive therapy. J Immunol 2014; 193:4988-99; PMID: 25305313; http://dx.doi.org/10.4049/jimmunol.1401776
   PubMed Web of Science ®Google Scholar
• Marks BR, Nowyhed HN, Choi JY, Poholek AC, Odegard JM, Flavell RA, Craft J. Thymic self-reactivity selects natural interleukin 17-producing T cells that can regulate peripheral inflammation. Nat Immunol 2009; 10:1125-32; PMID:19734905; http://dx.doi.org/10.1038/ni.1783
   PubMed Web of Science ®Google Scholar
• Chen Y, Haines CJ, Gutcher I, Hochweller K, Blumenschein WM, McClanahan T, Hämmerling G, Li MO, Cua DJ, McGeachy MJ. FoxP3(+) regulatory T cells promote T helper 17 cell development in vivo through regulation of interleukin-2. Immunity 2011; 34:409-21; PMID:21435588; http://dx.doi.org/10.1016/j.immuni.2011.02.011
   PubMed Web of Science ®Google Scholar
• Pandiyan P, Conti HR, Zheng L, Peterson AC, Mathern DR, Hernandez-Santos N, Edgerton M, Gaffen SL, Lenardo MJ. CD4(+)CD25(+)Foxp3(+) regulatory T cells promote Th17 cells in vitro and enhance host resistance in mouse Candida albicans Th17 cell infection model. Immunity 2011; 34:422-34; PMID:21435589; http://dx.doi.org/10.1016/j.immuni.2011.03.002
   PubMed Web of Science ®Google Scholar
• Delgoffe GM, Woo SR, Turnis ME, Gravano DM, Guy C, Overacre AE, Bettini ML, Vogel P, Finkelstein D, Bonnevier J et al. Stability and function of regulatory T cells is maintained by a neuropilin-1-semaphorin-4a axis. Nature 2013; 501:252-6; PMID:23913274; http://dx.doi.org/10.1038/nature12428
   PubMed Web of Science ®Google Scholar
• Williams LM, Rudensky AY. Maintenance of the Foxp3-dependent developmental program in mature regulatory T cells requires continued expression of Foxp3. Nat Immunol 2007; 8:277-84; PMID:17220892; http://dx.doi.org/10.1038/ni1437
   PubMed Web of Science ®Google Scholar
• Rubtsov YP, Niec RE, Josefowicz S, Li L, Darce J, Mathis D, Benoist C, Rudensky AY. Stability of the regulatory T cell lineage in vivo. Science 2010; 329:1667-71; PMID:20929851; http://dx.doi.org/10.1126/science.1191996
   PubMed Web of Science ®Google Scholar
• Zheng Y, Josefowicz S, Chaudhry A, Peng XP, Forbush K, Rudensky AY. Role of conserved non-coding DNA elements in the Foxp3 gene in regulatory T-cell fate. Nature 2010; 463:808-12; PMID:20072126; http://dx.doi.org/10.1038/nature08750
   PubMed Web of Science ®Google Scholar
• Miyao T, Floess S, Setoguchi R, Luche H, Fehling HJ, Waldmann H, Huehn J, Hori S. Plasticity of Foxp3(+) T cells reflects promiscuous Foxp3 expression in conventional T cells but not reprogramming of regulatory T cells. Immunity 2012; 36:262-75; PMID:22326580; http://dx.doi.org/10.1016/j.immuni.2011.12.012
   PubMed Web of Science ®Google Scholar
• Zhou X, Bailey-Bucktrout SL, Jeker LT, Penaranda C, Martinez-Llordella M, Ashby M, Nakayama M, Rosenthal W, Bluestone JA. Instability of the transcription factor Foxp3 leads to the generation of pathogenic memory T cells in vivo. Nat Immunol 2009; 10:1000-7; PMID:19633673; http://dx.doi.org/10.1038/ni.1774
   PubMed Web of Science ®Google Scholar
• Blatner NR, Mulcahy MF, Dennis KL, Scholtens D, Bentrem DJ, Phillips JD, Ham S, Sandall BP, Khan MW, Mahvi DM et al. Expression of RORgammat marks a pathogenic regulatory T cell subset in human colon cancer. Sci Transl Med 2012; 4:164ra59; PMID: 23241743; http://dx.doi.org/10.1126/scitranslmed.3004566
   Web of Science ®Google Scholar
• Komatsu N, Okamoto K, Sawa S, Nakashima T, Oh-hora M, Kodama T, Tanaka S, Bluestone JA, Takayanagi H. Pathogenic conversion of Foxp3+ T cells into TH17 cells in autoimmune arthritis. Nat Med 2014; 20:62-8; PMID:24362934; http://dx.doi.org/10.1038/nm.3432
   PubMed Web of Science ®Google Scholar
• Kryczek I, Wu K, Zhao E, Wei S, Vatan L, Szeliga W, Huang E, Greenson J, Chang A, Roliński J et al. IL-17+ regulatory T cells in the microenvironments of chronic inflammation and cancer. J Immunol 2011; 186:4388-95; PMID: 21357259; http://dx.doi.org/10.4049/jimmunol.1003251
   PubMed Web of Science ®Google Scholar
• Mercer F, Khaitan A, Kozhaya L, Aberg JA, Unutmaz D. Differentiation of IL-17-producing effector and regulatory human T cells from lineage-committed naive precursors. J Immunol 2014; 193:1047-54; PMID: 24958901; http://dx.doi.org/10.4049/jimmunol.1302936
   PubMed Web of Science ®Google Scholar
• Lin W, Haribhai D, Relland LM, Truong N, Carlson MR, Williams CB, Chatila TA. Regulatory T cell development in the absence of functional Foxp3. Nat Immunol 2007; 8:359-68; PMID:17273171; http://dx.doi.org/10.1038/ni1445
   PubMed Web of Science ®Google Scholar
• Zhou L, Lopes JE, Chong MM, Ivanov, II, Min R, Victora GD, Shen Y, Du J, Rubtsov YP, Rudensky AY et al. TGF-β-induced Foxp3 inhibits T(H)17 cell differentiation by antagonizing RORgammat function. Nature 2008; 453:236-40; PMID:18368049; http://dx.doi.org/10.1038/nature06878
   PubMed Web of Science ®Google Scholar
• Chaudhry A, Rudra D, Treuting P, Samstein RM, Liang Y, Kas A, Rudensky AY. CD4+ regulatory T cells control TH17 responses in a Stat3-dependent manner. Science 2009; 326:986-91; PMID:19797626; http://dx.doi.org/10.1126/science.1172702
   PubMed Web of Science ®Google Scholar
• Pearce EL, Poffenberger MC, Chang CH, Jones RG. Fueling immunity: insights into metabolism and lymphocyte function. Science 2013; 342:1242454; PMID:24115444; http://dx.doi.org/10.1126/science.1242454
   PubMedGoogle Scholar
• Barbi J, Pardoll D, Pan F. Metabolic control of the Treg/Th17 axis. Immunol Rev 2013; 252:52-77; PMID:23405895; http://dx.doi.org/10.1111/imr.12029
   PubMed Web of Science ®Google Scholar
• Smith PM, Howitt MR, Panikov N, Michaud M, Gallini CA, Bohlooly YM, Glickman JN, Garrett WS. The microbial metabolites, short-chain fatty acids, regulate colonic Treg cell homeostasis. Science 2013; 341:569-73; PMID:23828891; http://dx.doi.org/10.1126/science.1241165
   PubMed Web of Science ®Google Scholar
• Klotz L, Burgdorf S, Dani I, Saijo K, Flossdorf J, Hucke S, Alferink J, Nowak N, Beyer M, Mayer G et al. The nuclear receptor PPAR gamma selectively inhibits Th17 differentiation in a T cell-intrinsic fashion and suppresses CNS autoimmunity. J Exp Med 2009; 206:2079-89; PMID:19737866; http://dx.doi.org/10.1084/jem.20082771
   PubMed Web of Science ®Google Scholar
• Cipolletta D, Feuerer M, Li A, Kamei N, Lee J, Shoelson SE, Benoist C, Mathis D. PPAR-gamma is a major driver of the accumulation and phenotype of adipose tissue Treg cells. Nature 2012; 486:549-53; PMID:22722857; http://dx.doi.org/10.1038/nature11132
   PubMed Web of Science ®Google Scholar
• Carbo A, Hontecillas R, Kronsteiner B, Viladomiu M, Pedragosa M, Lu P, Philipson CW, Hoops S, Marathe M, Eubank S et al. Systems modeling of molecular mechanisms controlling cytokine-driven CD4+ T cell differentiation and phenotype plasticity. PLoS Comput Biol 2013; 9:e1003027; PMID:23592971; http://dx.doi.org/10.1371/journal.pcbi.1003027
   PubMed Web of Science ®Google Scholar
• Chuang HC, Sheu WH, Lin YT, Tsai CY, Yang CY, Cheng YJ, Huang PY, Li JP, Chiu LL, Wang X et al. HGK/MAP4K4 deficiency induces TRAF2 stabilization and Th17 differentiation leading to insulin resistance. Nat Commun 2014; 5:4602; PMID:25098764; http://dx.doi.org/10.1038/ncomms5602
   PubMed Web of Science ®Google Scholar
• Boniface K, Bak-Jensen KS, Li Y, Blumenschein WM, McGeachy MJ, McClanahan TK, McKenzie BS, Kastelein RA, Cua DJ, de Waal Malefyt R. Prostaglandin E2 regulates Th17 cell differentiation and function through cyclic AMP and EP2/EP4 receptor signaling. J Exp Med 2009; 206:535-48; PMID:19273625; http://dx.doi.org/10.1084/jem.20082293
   PubMed Web of Science ®Google Scholar
• Bergmann C, Strauss L, Zeidler R, Lang S, Whiteside TL. Expansion of human T regulatory type 1 cells in the microenvironment of cyclooxygenase 2 overexpressing head and neck squamous cell carcinoma. Cancer Res 2007; 67:8865-73; PMID:17875728; http://dx.doi.org/10.1158/0008-5472.CAN-07-0767
   PubMed Web of Science ®Google Scholar
• Kleinewietfeld M, Manzel A, Titze J, Kvakan H, Yosef N, Linker RA, Muller DN, Hafler DA. Sodium chloride drives autoimmune disease by the induction of pathogenic TH17 cells. Nature 2013; 496:518-22; PMID:23467095; http://dx.doi.org/10.1038/nature11868
   PubMed Web of Science ®Google Scholar
• Kretschmer K, Apostolou I, Hawiger D, Khazaie K, Nussenzweig MC, von Boehmer H. Inducing and expanding regulatory T cell populations by foreign antigen. Nat Immunol 2005; 6:1219-27; PMID:16244650; http://dx.doi.org/10.1038/ni1265
   PubMed Web of Science ®Google Scholar
• Ghoreschi K, Laurence A, Yang XP, Tato CM, McGeachy MJ, Konkel JE, Ramos HL, Wei L, Davidson TS, Bouladoux N et al. Generation of pathogenic T(H)17 cells in the absence of TGF-β signalling. Nature 2010; 467:967-71; PMID:20962846; http://dx.doi.org/10.1038/nature09447
   PubMed Web of Science ®Google Scholar
• Veldhoen M, Hocking RJ, Atkins CJ, Locksley RM, Stockinger B. TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity 2006; 24:179-89; PMID:16473830; http://dx.doi.org/10.1016/j.immuni.2006.01.001
   PubMed Web of Science ®Google Scholar
• Mangan PR, Harrington LE, O'Quinn DB, Helms WS, Bullard DC, Elson CO, Hatton RD, Wahl SM, Schoeb TR, Weaver CT. Transforming growth factor-β induces development of the T(H)17 lineage. Nature 2006; 441:231-4; PMID:16648837; http://dx.doi.org/10.1038/nature04754
   PubMed Web of Science ®Google Scholar
• Zhou L, Ivanov, II, Spolski R, Min R, Shenderov K, Egawa T, Levy DE, Leonard WJ, Littman DR. IL-6 programs T(H)-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways. Nat Immunol 2007; 8:967-74; PMID:17581537; http://dx.doi.org/10.1038/ni1488
   PubMed Web of Science ®Google Scholar
• Bettelli E, Carrier Y, Gao W, Korn T, Strom TB, Oukka M, Weiner HL, Kuchroo VK. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 2006; 441:235-8; PMID:16648838; http://dx.doi.org/10.1038/nature04753
   PubMed Web of Science ®Google Scholar
• Acosta-Rodriguez EV, Napolitani G, Lanzavecchia A, Sallusto F. Interleukins 1beta and 6 but not transforming growth factor-β are essential for the differentiation of interleukin 17-producing human T helper cells. Nat Immunol 2007; 8:942-9; PMID:17676045; http://dx.doi.org/10.1038/ni1496
   PubMed Web of Science ®Google Scholar
• Wilson NJ, Boniface K, Chan JR, McKenzie BS, Blumenschein WM, Mattson JD, Basham B, Smith K, Chen T, Morel F et al. Development, cytokine profile and function of human interleukin 17-producing helper T cells. Nat Immunol 2007; 8:950-7; PMID:17676044; http://dx.doi.org/10.1038/ni1497
   PubMed Web of Science ®Google Scholar
• Zhu J, Davidson TS, Wei G, Jankovic D, Cui K, Schones DE, Guo L, Zhao K, Shevach EM, Paul WE. Down-regulation of Gfi-1 expression by TGF-β is important for differentiation of Th17 and CD103+ inducible regulatory T cells. J Exp Med 2009; 206:329-41; PMID:19188499; http://dx.doi.org/10.1084/jem.20081666
   PubMed Web of Science ®Google Scholar
• Davidson TS, DiPaolo RJ, Andersson J, Shevach EM. Cutting Edge: IL-2 is essential for TGF-β-mediated induction of Foxp3+ T regulatory cells. J Immunol 2007; 178:4022-6; PMID: 17371955; http://dx.doi.org/10.4049/jimmunol.178.7.4022
   PubMed Web of Science ®Google Scholar
• Laurence A, Tato CM, Davidson TS, Kanno Y, Chen Z, Yao Z, Blank RB, Meylan F, Siegel R, Hennighausen L et al. Interleukin-2 signaling via STAT5 constrains T helper 17 cell generation. Immunity 2007; 26:371-81; PMID:17363300; http://dx.doi.org/10.1016/j.immuni.2007.02.009
   PubMed Web of Science ®Google Scholar
• Bettelli E, Korn T, Oukka M, Kuchroo VK. Induction and effector functions of T(H)17 cells. Nature 2008; 453:1051-7; PMID:18563156; http://dx.doi.org/10.1038/nature07036
   PubMed Web of Science ®Google Scholar
• Jayaraman P, Alfarano MG, Svider PF, Parikh F, Lu G, Kidwai S, Xiong H, Sikora AG. iNOS Expression in CD4+ T Cells Limits Treg Induction by Repressing TGFbeta1: Combined iNOS Inhibition and Treg Depletion Unmask Endogenous Antitumor Immunity. Clin Cancer Res 2014; 20(24):6439-51; PMID: 25278453; http://dx.doi.org/10.1158/1078-0432.CCR-13-3409
   PubMed Web of Science ®Google Scholar
• Jianjun Y, Zhang R, Lu G, Shen Y, Peng L, Zhu C, Cui M, Wang W, Arnaboldi P, Tang M et al. T cell-derived inducible nitric oxide synthase switches off Th17 cell differentiation. J Exp Med 2013; 210:1447-62; PMID:23797094; http://dx.doi.org/10.1084/jem.20122494
   PubMed Web of Science ®Google Scholar
• Hoechst B, Gamrekelashvili J, Manns MP, Greten TF, Korangy F. Plasticity of human Th17 cells and iTregs is orchestrated by different subsets of myeloid cells. Blood 2011; 117:6532-41; PMID:21493801; http://dx.doi.org/10.1182/blood-2010-11-317321
   PubMed Web of Science ®Google Scholar
• Obermajer N, Muthuswamy R, Lesnock J, Edwards RP, Kalinski P. Positive feedback between PGE2 and COX2 redirects the differentiation of human dendritic cells toward stable myeloid-derived suppressor cells. Blood 2011; 118:5498-505; PMID:21972293; http://dx.doi.org/10.1182/blood-2011-07-365825
   PubMed Web of Science ®Google Scholar
• Ericksen RE, Rose S, Westphalen CB, Shibata W, Muthupalani S, Tailor Y, Friedman RA, Han W, Fox JG, Ferrante AW Jr et al. Obesity accelerates Helicobacter felis-induced gastric carcinogenesis by enhancing immature myeloid cell trafficking and TH17 response. Gut 2014; 63:385-94; PMID:23729675; http://dx.doi.org/10.1136/gutjnl-2013-305092
   PubMed Web of Science ®Google Scholar
• Sharma MD, Hou DY, Liu Y, Koni PA, Metz R, Chandler P, Mellor AL, He Y, Munn DH. Indoleamine 2,3-dioxygenase controls conversion of Foxp3+ Tregs to TH17-like cells in tumor-draining lymph nodes. Blood 2009; 113:6102-11; PMID:19366986; http://dx.doi.org/10.1182/blood-2008-12-195354
   PubMed Web of Science ®Google Scholar
• Chaudhry A, Samstein RM, Treuting P, Liang Y, Pils MC, Heinrich JM, Jack RS, Wunderlich FT, Brüning JC, Müller W et al. Interleukin-10 signaling in regulatory T cells is required for suppression of Th17 cell-mediated inflammation. Immunity 2011; 34:566-78; PMID:21511185; http://dx.doi.org/10.1016/j.immuni.2011.03.018
   PubMed Web of Science ®Google Scholar
• Keerthivasan S, Aghajani K, Dose M, Molinero L, Khan MW, Venkateswaran V, Weber C, Emmanuel AO, Sun T, Bentrem DJ et al. β-Catenin promotes colitis and colon cancer through imprinting of proinflammatory properties in T cells. Sci Transl Med 2014; 6:225ra28; PMID: 24574339; http://dx.doi.org/10.1126/scitranslmed.3007607
   PubMed Web of Science ®Google Scholar
• Viaud S, Saccheri F, Mignot G, Yamazaki T, Daillere R, Hannani D, Enot DP, Pfirschke C, Engblom C, Pittet MJ et al. The intestinal microbiota modulates the anticancer immune effects of cyclophosphamide. Science 2013; 342:971-6; PMID:24264990; http://dx.doi.org/10.1126/science.1240537
   PubMed Web of Science ®Google Scholar